Canaan VII

Canaan VII is an early-stage venture capital fund managed by Canaan Partners, a global firm established in 1987 and based in San Francisco, California. The fund focuses on investing in the software and technology, media, and telecommunications (TMT) sectors within the United States. Canaan Partners manages a diverse portfolio with over 190 exits and has invested in more than 250 companies across various industries, including fintech, healthcare, and digital health. The firm employs a team of experienced investment professionals who seek to support visionary entrepreneurs with innovative ideas, providing capital ranging from $1 million to $20 million across different stages of development. With approximately $5 billion under management across multiple funds, Canaan Partners continues to play a significant role in fostering growth within the technology and healthcare landscapes.

Brent Ahrens

General Partner

Brenton K. Ahrens

General Partner - West Coast

Nandu Anilal

Investor

John Balen

Partner - West Coast

Joydeep Bhattacharyya

General Partner - West Coast

Stephen Bloch

General Partner - East Coast

Laura Chau

Partner

Daniel T. Ciporin

General Partner

Colleen Cuffaro

Partner

Brendan Dickinson

General Partner

Peter Farina Ph.D

Executive in Residence - East Coast

Rayfe Gaspar-Asaoka

Partner

Julie Grant

General Partner - West Coast

Nairi Hourdajian

Vice President, Marketing and Communications

Wende Hutton

General Partner - West Coast

Maha Ibrahim

General Partner

Deepak Kamra

General Partner - West Coast

Nina Kjellson

General Partner

Ehud Levy

Co-Founder & General Partner, Canaan Partners Israel

Jared Newman

Investor

John Pacifico

General Partner, Chief Operating Officer, and Chief Financial Officer - East Coast

Hootan Rashidifard

Principal

Guy Russo

General Partner - East Coast

Timothy Shannon

General Partner - East Coast

Hrach Simonian

General Partner

Bob Williams

Venture Partner

Eric Young

Co-Founder and Partner - West Coast

Past deals in Minnesota

Instrumental

Series C in 2022
Instrumental, Inc. specializes in developing software that enhances the efficiency of assembly lines by enabling them to operate autonomously, learn, and adapt to various processes. Founded by former Apple engineers Anna-Katrina Shedletsky and Samuel Weiss, the company aims to address inefficiencies in manufacturing, ultimately saving significant costs related to scrap and rework. Instrumental's software allows manufacturers to quickly identify and resolve issues on their assembly lines, thereby preventing production delays and improving yield rates. The service is employed by leading manufacturers globally and focuses on analytics that provide insights into assembly line performance, allowing engineers to evaluate part dimensions and diagnose problems in real-time without needing physical access to the production environment. Based in Saint Paul, Minnesota, Instrumental combines its software capabilities with a range of consulting and integration services to support both commercial enterprises and government agencies in optimizing their operations.

Relievant Medsystems

Venture Round in 2020
Relievant Medsystems, Inc. is a medical device company focused on developing innovative treatments for chronic axial low back pain. The company's primary offering is the Intracept procedure, which targets the basivertebral nerve to relieve vertebrogenic low back pain through a minimally invasive approach. Founded in 2004 and headquartered in Minneapolis, Minnesota, with an additional development and operations office in Sunnyvale, California, Relievant aims to provide low-risk therapeutic options that enhance the quality of life for patients suffering from this prevalent condition.

Instrumental

Series B in 2020
Instrumental, Inc. specializes in developing software that enhances the efficiency of assembly lines by enabling them to operate autonomously, learn, and adapt to various processes. Founded by former Apple engineers Anna-Katrina Shedletsky and Samuel Weiss, the company aims to address inefficiencies in manufacturing, ultimately saving significant costs related to scrap and rework. Instrumental's software allows manufacturers to quickly identify and resolve issues on their assembly lines, thereby preventing production delays and improving yield rates. The service is employed by leading manufacturers globally and focuses on analytics that provide insights into assembly line performance, allowing engineers to evaluate part dimensions and diagnose problems in real-time without needing physical access to the production environment. Based in Saint Paul, Minnesota, Instrumental combines its software capabilities with a range of consulting and integration services to support both commercial enterprises and government agencies in optimizing their operations.

Relievant Medsystems

Series E in 2018
Relievant Medsystems, Inc. is a medical device company focused on developing innovative treatments for chronic axial low back pain. The company's primary offering is the Intracept procedure, which targets the basivertebral nerve to relieve vertebrogenic low back pain through a minimally invasive approach. Founded in 2004 and headquartered in Minneapolis, Minnesota, with an additional development and operations office in Sunnyvale, California, Relievant aims to provide low-risk therapeutic options that enhance the quality of life for patients suffering from this prevalent condition.

Relievant Medsystems

Series D in 2016
Relievant Medsystems, Inc. is a medical device company focused on developing innovative treatments for chronic axial low back pain. The company's primary offering is the Intracept procedure, which targets the basivertebral nerve to relieve vertebrogenic low back pain through a minimally invasive approach. Founded in 2004 and headquartered in Minneapolis, Minnesota, with an additional development and operations office in Sunnyvale, California, Relievant aims to provide low-risk therapeutic options that enhance the quality of life for patients suffering from this prevalent condition.

Relievant Medsystems

Series D in 2012
Relievant Medsystems, Inc. is a medical device company focused on developing innovative treatments for chronic axial low back pain. The company's primary offering is the Intracept procedure, which targets the basivertebral nerve to relieve vertebrogenic low back pain through a minimally invasive approach. Founded in 2004 and headquartered in Minneapolis, Minnesota, with an additional development and operations office in Sunnyvale, California, Relievant aims to provide low-risk therapeutic options that enhance the quality of life for patients suffering from this prevalent condition.

Relievant Medsystems

Series C in 2009
Relievant Medsystems, Inc. is a medical device company focused on developing innovative treatments for chronic axial low back pain. The company's primary offering is the Intracept procedure, which targets the basivertebral nerve to relieve vertebrogenic low back pain through a minimally invasive approach. Founded in 2004 and headquartered in Minneapolis, Minnesota, with an additional development and operations office in Sunnyvale, California, Relievant aims to provide low-risk therapeutic options that enhance the quality of life for patients suffering from this prevalent condition.

CoAxia

Series D in 2009
CoAxia is a medical device company located in Minneapolis, Minnesota, specializing in the research and development of therapies and treatment solutions for cerebral ischemia. The company's focus is on advancing medical technologies to address conditions associated with reduced blood flow to the brain, aiming to improve patient outcomes through innovative interventions.

Transoma Medical

Series D in 2008
Transoma Medicalis a provider of implantable wireless diagnostic systems for patients with chronic cardiovascular disease and for biomedical research. The company’s products include small wireless sensors that transmit information from inside the body to a receiver via radio-frequency waves, as well as unique software to condense the data these devices provide into meaningful information.

CoAxia

Series C in 2008
CoAxia is a medical device company located in Minneapolis, Minnesota, specializing in the research and development of therapies and treatment solutions for cerebral ischemia. The company's focus is on advancing medical technologies to address conditions associated with reduced blood flow to the brain, aiming to improve patient outcomes through innovative interventions.

Transoma Medical

Series C in 2007
Transoma Medicalis a provider of implantable wireless diagnostic systems for patients with chronic cardiovascular disease and for biomedical research. The company’s products include small wireless sensors that transmit information from inside the body to a receiver via radio-frequency waves, as well as unique software to condense the data these devices provide into meaningful information.

Relievant Medsystems

Series B in 2006
Relievant Medsystems, Inc. is a medical device company focused on developing innovative treatments for chronic axial low back pain. The company's primary offering is the Intracept procedure, which targets the basivertebral nerve to relieve vertebrogenic low back pain through a minimally invasive approach. Founded in 2004 and headquartered in Minneapolis, Minnesota, with an additional development and operations office in Sunnyvale, California, Relievant aims to provide low-risk therapeutic options that enhance the quality of life for patients suffering from this prevalent condition.

CoAxia

Series C in 2006
CoAxia is a medical device company located in Minneapolis, Minnesota, specializing in the research and development of therapies and treatment solutions for cerebral ischemia. The company's focus is on advancing medical technologies to address conditions associated with reduced blood flow to the brain, aiming to improve patient outcomes through innovative interventions.

Transoma Medical

Series B in 2005
Transoma Medicalis a provider of implantable wireless diagnostic systems for patients with chronic cardiovascular disease and for biomedical research. The company’s products include small wireless sensors that transmit information from inside the body to a receiver via radio-frequency waves, as well as unique software to condense the data these devices provide into meaningful information.

CoAxia

Series B in 2004
CoAxia is a medical device company located in Minneapolis, Minnesota, specializing in the research and development of therapies and treatment solutions for cerebral ischemia. The company's focus is on advancing medical technologies to address conditions associated with reduced blood flow to the brain, aiming to improve patient outcomes through innovative interventions.

Transoma Medical

Series A in 2002
Transoma Medicalis a provider of implantable wireless diagnostic systems for patients with chronic cardiovascular disease and for biomedical research. The company’s products include small wireless sensors that transmit information from inside the body to a receiver via radio-frequency waves, as well as unique software to condense the data these devices provide into meaningful information.